| 梁喜鹏,常 浩,曲峻峰,王 巨,王胜发.miR-182靶向抑制FBXW7表达影响非小细胞肺癌细胞增殖研究[J].现代生物医学进展英文版,2019,19(22):4213-4219. |
| miR-182靶向抑制FBXW7表达影响非小细胞肺癌细胞增殖研究 |
| MiR-182 Promotes Cell Proliferation of Non-small Cell Lung Cancer by Suppressing FBXW7 |
| Received:April 15, 2019 Revised:May 10, 2019 |
| DOI：10.13241/j.cnki.pmb.2019.22.003 |
| 中文关键词: miR-182 FBXW7 非小细胞肺癌 |
| 英文关键词: miR-182 FBXW7 NSCLC |
| 基金项目:黑龙江省教育厅海外学人科研资助项目(1152hq30) |
| Author Name | Affiliation | E-mail | | LIANG Xi-peng | Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China | 839250015@qq.com | | CHANG Hao | Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China | | | QU Jun-feng | Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China | | | WANG Ju | Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China | | | WANG Sheng-fa | Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China | |
|
| Hits: 1059 |
| Download times: 857 |
| 中文摘要: |
| 摘要 目的：研究microRNA-182(miR-182)在非小细胞肺癌(NSCLC)组织中的表达，并探讨其对NSCLC细胞增殖的影响及作用机制。方法：采用实时荧光定量PCR(qRT-PCR)检测miR-182在11例NSCLC及相应癌旁组织中的表达情况；Western blot检测FBXW7，c-Jun，c-Myc及cyclin D蛋白的表达；将miR-182模拟物，抑制物及相应空白对照瞬时转染H460细胞后，以细胞增殖与活性检测和克隆形成实验检测细胞系的增殖情况；流式细胞术检测细胞周期和凋亡变化；荧光素酶报告基因实验证实miR-182对FBXW7的靶向性作用。结果：NSCLC组织中miR-182的相对表达水平显著高于癌旁组织(P<0.05)。转染组与对照组相比，H460细胞生长、克隆形成能力显著增强，细胞周期进程加快，细胞凋亡受到抑制(P<0.05)。在NSCLC组织中，FBXW7蛋白的表达水平明显低于癌旁组织(P<0.05)。miR-182 mimics显著降低野生型FBXW7质粒荧光素酶的活性，然而将结合位点突变后，miR-182 mimics则不再影响荧光素酶的活性。结论：miR-182在NSCLC组织中高表达，与FBXW7之间存在靶向关系，通过下调FBXW7蛋白表达促进NSCLC细胞的增殖，参与肿瘤的发生发展，预示其可能成为一种潜在的生物标志和治疗靶点。 |
| 英文摘要: |
| ABSTRACT Objective: To investigate the expression of microRNA-182(miR-182) in the non-small cell lung cancer (NSCLC) tissues and its effect and mechanism on the proliferation of NSCLC cells. Methods: The expression of miR-182 in the malignant NSCLC tissue and adjacent normal tissue was estimated by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The Levels of FBXW7 and corresponding substrates were detected by western blot. Cell growth was detected by counting kit (CCK)-8 reagent and colony formation experiment. Cell cycle progression and cell apoptosis were determined through flow cytometry. The effect of miR-182 on the FBXW7 was determined using the Dual-Luciferase Reporter Assay System. Results: Compared with the adjacent normal tissues, the expression of miR-182 was significantly upregulated in the NSCLC tissues(P<0.05). Compared with the control group, the capacity of cell growth, colony formation capacity and cell cycle progression were dramatically increased, the apoptosis was decreased in the transfection group(P<0.05). In addition, the expression of FBXW7 protein was downregulated in the NSCLC tissus(P<0.05). The activity of luciferase in wild-type FBXW7 plasmid was significantly decreased by miRNA-182 mimics. However, the activity of luciferase hadn't been affected by miRNA-182 mimics after mutation of binding site. Conclusion: The expression of miR-182 was up-regulated in the NSCLC tissues, which can promote the proliferation of NSCLC cells and participates in the occurrence and development of tumors by down-regulating the expression of FBXW7. |
|
View Full Text
View/Add Comment Download reader |
| Close |
|
|
|
